Board of Directors
Chairman of the Board
MBA. Born 1958. Lives near Amsterdam, Netherlands. Provides presently interim management solutions and consulting to companies. He served as a Board Member in BioInvent between 2016-2017. Previously executive and supervisory positions in a number of biotech companies, such as SkylineDx, BBB Therapeutics and ProFibrix. Between 1998-2011, he served as CFO and member of the board of Crucell NV, and he has also held senior executive positions at Royal Boskalis, TIP GE Capital and Continental Can Inc. Chairman of the Board since 2018. Chairman of the Remuneration Committee and member of the Audit Committee.
Other board appointments: Member of the Board of Karmijn Kapitaal Investments.
M.Sc. Molecular and functional biology. Born 1959 Lives in Lund, Sweden. Senior Research Engineer. Member of the Board since 2013.
Other board appointments: -
Shareholding: 20,850 (own and affiliated holdings)
Consultant. Born 1968. Lives in Stockholm. Extensive experience from financial markets, active within the financial industry between 1989-2012 with experience in asset management, institutional equities and investment banking. Has previously held different managerial positions within Handelsbanken, Deutsche Bank and Nordea. Has previously served on the Board of the Swedish Securities Dealers Association. Member of the Board since 2018. Chairman of the Audit Committee.
Other board appointments: Member of the Board of Evolvere Partners AB.
Shareholding: 820,000 (whereof 120,000 in Sw. kapitalförsäkring)
M.Sc. in Aerospace Engineering and M.Sc. in Business Economics. Born 1976. Lives in the Netherlands. CEO of SkylineDx since 2013. He is also currently the CEO of Quorics, Managing Director at Exponential BV, and Fund Manager at Swanbridge Capital. Extensive board experience within life science in current and previous board roles at Agendia, Bioinvent (2013-2016), deVGen, Innate Pharma, and Octoplus. Member of the Board since 2017. Member of the Audit Committee.
Other board appointments: Chairman of the Board of DCPrime. Member of the Boards of Isobionics and VitalneXt.
Elin Jaensson Gyllenbäck
Ph.D. in Immunology. Born 1979. Lives in Lund, Sweden. Senior Research Scientist. Member of the Board since 2017.
Other board appointments: -
An van Es Johansson
M.D. Born 1960. Lives in Stockholm, Sweden. Vice President and Head of Medical Affairs at Swedish Orphan Biovitrum AB (Sobi). Previously different executive positions in Clinical Development, Medical Affairs, Business Development and Commercial within Sobi, Eli Lilly, Roche, Pharmacia & Upjohn and biotech companies in USA, the Netherlands, Switzerland and Sweden. Member of the BioInvent Board since 2016. Member of the Remuneration Committee.
Other board appointments: Member of the Board of AlzeCure.
CFA, Ph.D. Born 1968. Lives in Commugny, Switzerland. Venture partner Omega Funds. Former partner Private Equity Sectoral Asset Management. Researcher at University of Geneva. Research analyst at Pictet Bank. Member of the BioInvent Board since 2016.
Other board appointments: Member of the Boards of Andrew Alliance, Etherna Immunotherapies, Immunic, LifeSpan, Sophia Genetics and Board observer of Anaconda Brain.
Doctor of Medicine and Doctor of Neurobiology. Born 1956. Lives Stockton, New Jersey, USA. Serves currently as chairman and board member in a number of biotech companies in the U.S., Europe and Canada. Previously President & CEO of GPC Biotech, Executive Vice President and Chief Scientific Officer of Genome Therapeutics Corporation and Vice President of Oncology Drug Discovery and - in parallel - Vice President of Corporate and Academic Alliances at Bristol-Myers Squibb. Member of the BioInvent Board since 2018. Member of the Remuneration Committee.
Other board appointments: Chairman of the board in Oxford BioTherapeutics, Co-Founder and Executive Chairman/Acting CEO in CryptoMedix. Board member and Chairman of the Scientific and Clinical Advisory Board in Opsona, board member and Co-Chair of the Scientific Advisory Board of Oncolytics and board member of Aprea and Vaccibody.